Staged treatment of patients with rheumatoid arthritis at a health resort with sulfide waters
Khetagurova, Z.V.; Ambalova, S.A.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 63-65
1985
ISSN/ISBN: 0042-8787 PMID: 4036060 Document Number: 248367
Document emailed within 1 workday
Related Documents
Popovich, G.A. 1984: Staged treatment of rheumatoid arthritis patients using hydrogen sulfide baths and peat-mud applications for the Konopkivka spring Vrachebnoe Delo 8: 24-27Veinpalu, E.I. 1979: Health resort treatment of rheumatoid arthritis Terapevticheskii Arkhiv 51(7): 39-44
Zahorska, Z.; Fiedot, H. 1985: Health resort treatment of children with rheumatoid arthritis Pediatria Polska 60(3): 267-270
Trink, R.F. 1984: Evaluation of the effectiveness of health resort therapy of rheumatoid arthritis patients Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 40-42
Tomaeva, T.G. 1982: Changes in the vascular-thrombocytic hemostasis in rheumatic patients after health resort treatment including hydrogen sulfide baths Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1982(6): 60-61
Ivanova, M.V.; Mikol'ian, V.K. 1985: Effect of sanatorium and health resort treatment on the immunological indices of children with rheumatoid arthritis Pediatriia 8: 66-67
Mikol'ian, V.K.; Kaladze, N.N. 1987: Clinico-immunologic substantiation of the duration of sanatorio-health resort treatment of children with rheumatoid arthritis Pediatriia 7: 37-40
Musher, I.M.; Martynenko, A.A. 1971: Treatment of adolescents with peptic ulcer at the 6berezovsk Mineral Waters" Health Resort Vrachebnoe Delo 3: 74-77
Terent'eva, L.A. 1972: Sulfide (hydrogen sulfide) waters and their therapeutic use Meditsinskaia Sestra 31(11): 23-25
Deriabin, A.V.; Likov, A.F.; Zhidkova, T.Z.; Tkachenko, V.A. 1988: Current methods of follow-up and correction of the performance of the physical rehabilitation of patients with ischemic heart disease at sanatoria of the Caucasian Mineral Waters health resort Terapevticheskii Arkhiv 60(2): 116-118
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Solov'eva, L.A.; Babur, L.I.; Klimas, L.A.; Shevchuk, S.N. 1985: Morphofunctional signs of the body adaptation of animals exposed to the carbonate and radon waters of the Khmel'nik health resort Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 43-45
Salaffi, F.; Sarzi-Puttini, P.; Girolimetti, R.; Atzeni, F.; Gasparini, S.; Grassi, W. 2009: Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey Clinical and Experimental Rheumatology 27(5 Suppl 56: S67-S74
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Maini, R.N.; Wolfe, F. 1999: Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritis Rheumatology 38 Suppl. 2: 48-49
Barov, B. 1985: Use of sulfide mineral waters in the People's Republic of Bulgaria Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 70-71
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Yoshimatsu, S. 1977: Community health care of patients with rheumatoid arthritis in Nagano Prefecture Ryumachi 17(6): 556-558
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571